Innate Pharma GAAP EPS of -€0.73, revenue of €57.67M (NASDAQ:IPHA) March 22, 2023March 22, 2023 · Business · By ReportWire Innate Pharma GAAP EPS of -€0.73, revenue of €57.67M Source link
